These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15041033)

  • 1. The use of eicosapentaenoic acid in the treatment of chronic fatigue syndrome.
    Puri BK
    Prostaglandins Leukot Essent Fatty Acids; 2004 Apr; 70(4):399-401. PubMed ID: 15041033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton and 31-phosphorus neurospectroscopy in the study of membrane phospholipids and fatty acid intervention in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis) and dyslexia.
    Puri BK
    Int Rev Psychiatry; 2006 Apr; 18(2):145-7. PubMed ID: 16777668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 31-phosphorus neurospectroscopy study of omega-3 long-chain polyunsaturated fatty acid intervention with eicosapentaenoic acid and docosahexaenoic acid in patients with chronic refractory epilepsy.
    Puri BK; Koepp MJ; Holmes J; Hamilton G; Yuen AW
    Prostaglandins Leukot Essent Fatty Acids; 2007 Aug; 77(2):105-7. PubMed ID: 17761409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosapentaenoic acid-rich essential fatty acid supplementation in chronic fatigue syndrome associated with symptom remission and structural brain changes.
    Puri BK; Holmes J; Hamilton G
    Int J Clin Pract; 2004 Mar; 58(3):297-9. PubMed ID: 15117099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution magnetic resonance imaging sinc-interpolation-based subvoxel registration and semi-automated quantitative lateral ventricular morphology employing threshold computation and binary image creation in the study of fatty acid interventions in schizophrenia, depression, chronic fatigue syndrome and Huntington's disease.
    Puri BK
    Int Rev Psychiatry; 2006 Apr; 18(2):149-54. PubMed ID: 16777669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans.
    Mori TA; Woodman RJ
    Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):95-104. PubMed ID: 16477172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fish oil, lean tissue, and cancer: is there a role for eicosapentaenoic acid in treating the cancer anorexia/weight loss syndrome?
    Jatoi A
    Crit Rev Oncol Hematol; 2005 Jul; 55(1):37-43. PubMed ID: 15927842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-chain polyunsaturated fatty acids and the pathophysiology of myalgic encephalomyelitis (chronic fatigue syndrome).
    Puri BK
    J Clin Pathol; 2007 Feb; 60(2):122-4. PubMed ID: 16935966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation.
    Maes M; Mihaylova I; Leunis JC
    Neuro Endocrinol Lett; 2005 Dec; 26(6):745-51. PubMed ID: 16380690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic fatigue syndrome: studies on skeletal muscle.
    Grau JM; Casademont J; Pedrol E; Fernández-Solà J; Cardellach F; Barros N; Urbano-Márquez A
    Clin Neuropathol; 1992; 11(6):329-32. PubMed ID: 1473316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutritional strategies for treating chronic fatigue syndrome.
    Werbach MR
    Altern Med Rev; 2000 Apr; 5(2):93-108. PubMed ID: 10767667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'?
    Su KP
    Neurosignals; 2009; 17(2):144-52. PubMed ID: 19190401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can perinatal supplementation of long-chain polyunsaturated fatty acids prevents schizophrenia in adult life?
    Das UN
    Med Sci Monit; 2004 Dec; 10(12):HY33-7. PubMed ID: 15567990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of n-3 fatty acid supplementation in patients with asthma.
    Wong KW
    J Am Diet Assoc; 2005 Jan; 105(1):98-105. PubMed ID: 15635353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omacor (prescription omega-3-acid ethyl esters 90): From severe rhythm disorders to hypertriglyceridemia.
    Rupp H
    Adv Ther; 2009 Jul; 26(7):675-90. PubMed ID: 19629408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of omega-3 fatty acid supplementation on the arachidonic acid:eicosapentaenoic acid ratio.
    Burns T; Maciejewski SR; Hamilton WR; Zheng M; Mooss AN; Hilleman DE
    Pharmacotherapy; 2007 May; 27(5):633-8. PubMed ID: 17461697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prescription omega-3 fatty acids in the treatment of hypertriglyceridemia.
    McKenney JM; Sica D
    Pharmacotherapy; 2007 May; 27(5):715-28. PubMed ID: 17461707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
    Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
    J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional strategies for treating chronic fatigue syndrome.
    Logan AC
    Altern Med Rev; 2001 Feb; 6(1):4-6. PubMed ID: 11207453
    [No Abstract]   [Full Text] [Related]  

  • 20. A trial of omega-3 fatty acids for prevention of hypertension.
    Dokholyan RS; Albert CM; Appel LJ; Cook NR; Whelton P; Hennekens CH
    Am J Cardiol; 2004 Apr; 93(8):1041-3. PubMed ID: 15081453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.